The company develops preventive, therapeutic, and oncolytic vaccines for infectious diseases and cancer immunotherapy, with a particular focus on diseases like HCV, HPV, HSV, HIV, and malaria. Profectus BioSciences harnesses the immune system through the delivery of their proprietary prime/boost vaccines and small molecules to reduce the morbidity and mortality caused by viral diseases, especially HIV.